Nuvalent, Inc.
NUVL • NASDAQ
Nuvalent, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO James R. Porter, with a market cap of $8.0B.
CEOJames R. Porter
Next Earnings
Upcoming earnings announcement for Nuvalent, Inc.
Date
Thursday, May 7, 2026 (in 2 months)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.32
Earnings History
Past 12 earnings reports for Nuvalent, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | Q4 2025 | -$1.58Est: -$1.45 | -9.0% | - | — |  10-K |
| Oct 30, 2025 | Q3 2025 | -$1.70Est: -$1.35 | -25.9% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$1.39Est: -$1.20 | -15.8% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$1.18Est: -$1.06 | -11.3% | - | — | 10-Q |
| Feb 27, 2025 | Q4 2024 | -$1.05Est: -$1.05 | 0.0% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$1.28Est: -$0.94 | -36.2% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.88Est: -$0.76 | -15.8% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.69Est: -$0.66 | -4.5% | - | — | 10-Q |
| Feb 27, 2024 | Q4 2023 | -$0.62Est: -$0.60 | -3.3% | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.59Est: -$0.58 | -1.7% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.51Est: -$0.53 | +3.8% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.44Est: -$0.51 | +13.7% | - | — | — |